HiSeq Sales Boost Illumina's Q3 Revenues, but Order Backlog Will Take Several Quarters to Fill

The company is also updating its portfolio of sequencers: It launched the HiSeq 1000, reduced the list price for the GAIIx, and said it will discontinue the GAIIe.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.